Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction

BACKGROUND A simple clinical method to stratify risk for patients who have had successful reperfusion therapy after myocardial infarction is attractive since it facilitates the tailoring of therapy. METHODS We investigated the clinical value of the 12-lead electrocardiogram (ECG), in 403 patients after successful reperfusion therapy by primary coronary angioplasty, in relation to infarct size measured by enzyme activity, left-ventricular function, and clinical outcome. ECGs were analysed to find the extent of the ST-segment-elevation resolution 1 h after reperfusion therapy. FINDINGS A normalised ST segment was seen in 51% of patients, a partly normalised ST segment in 34%, and 15% had no ST-segment-elevation resolution. Enzymatic infarct size and ejection fraction were related to the extent of the early resolution of the ST segment. The relative risk of death among patients with no resolution compared with patients with a normalised ST segment was 8.7 (95% CI 3.7-20.1), and that among patients with partial resolution compared with patients with a normalised ST segment was 3.6 (1.6-8.3). INTERPRETATION Our findings suggest that ECG patterns reflect the effectiveness of myocardial reperfusion. Patients for whom reperfusion therapy by primary angioplasty was successful and who had normalised ST segments had limited damage to the myocardium and an excellent outlook during follow-up. Patients with persistent ST elevation after reperfusion therapy may need additional interventions since they have more extensive myocardial damage and have a higher mortality rate.

[1]  C. Wong,et al.  Intracoronary stenting in acute myocardial infarction. , 1994, Catheterization and cardiovascular diagnosis.

[2]  J. Reiber,et al.  Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction. , 1995, European heart journal.

[3]  P. Serruys,et al.  Effects of early intracoronary streptokinase on infarct size estimated from cumulative enzyme release and on enzyme release rate: a randomized trial of 533 patients with acute myocardial infarction. , 1986, American heart journal.

[4]  R. Ferrari.  Metabolic disturbances during myocardial ischemia and reperfusion. , 1995, The American journal of cardiology.

[5]  K. Rentrop.  Restoration of anterograde flow in acute myocardial infarction: the first 15 years. , 1995, Journal of the American College of Cardiology.

[6]  Gusto Angiographic Investigators.  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.

[7]  K. Lee,et al.  Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction. , 1990, The American journal of cardiology.

[8]  J O'Keefe,et al.  A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .

[9]  R. Califf,et al.  Use of Aortic Counterpulsation to Improve Sustained Coronary Artery Patency During Acute Myocardial Infarction: Results of a Randomized Trial , 1994, Circulation.

[10]  T. Böhm,et al.  Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial. , 1997, European heart journal.

[11]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[12]  D. Cox.  Regression Models and Life-Tables , 1972 .

[13]  H. Hod,et al.  Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction. , 1990, British heart journal.

[14]  M. Hori,et al.  Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. , 1996, Circulation.

[15]  M. Simoons,et al.  Effect of thrombolytic treatment delay on myocardial infarct size , 1992, The Lancet.

[16]  H. Suryapranata,et al.  Limitation of Infarct Size and Preservation of Left Ventricular Function After Primary Coronary Angioplast Compared With Intravenous Streptokinase in Acute Myocardial Infarction , 1994, Circulation.

[17]  J. Reiber,et al.  A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. , 1993, The New England journal of medicine.

[18]  R. Califf,et al.  Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. , 1988, Annals of internal medicine.

[19]  A. Kitabatake,et al.  Lack of Myocardial Perfusion Immediately After Successful Thrombolysis: A Predictor of Poor Recovery of Left Ventricular Function in Anterior Myocardial Infarction , 1992, Circulation.

[20]  P. Kudenchuk,et al.  Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. , 1993, JAMA.

[21]  Epic Investigators,et al.  Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. , 1994, The New England journal of medicine.

[22]  K. Fujimori,et al.  Postischemic functional recovery and BMIPP uptake after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. , 1996, The American journal of cardiology.

[23]  C. Peterson.  A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction: Grines CL, Browne KF, Marco J, et al. N Engl J Med 328:673–679 Mar 1993 , 1993 .

[24]  R. Jeremy,et al.  Relation between ischemia time, infarct size, and left ventricular function in humans. , 1995, Circulation.

[25]  K. Wegscheider,et al.  Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. , 1994, Journal of the American College of Cardiology.

[26]  M. Simoons,et al.  Enzyme tests in the evaluation of thrombolysis in acute myocardial infarction. , 1988, British heart journal.

[27]  P. Armstrong,et al.  Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial. , 1996, European heart journal.

[28]  Johan Herlitz,et al.  Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .

[29]  A. Maggioni,et al.  A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent. A Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2)-Derived Analysis. , 1994, Journal of the American College of Cardiology.

[30]  F. Van de Werf,et al.  Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism, and function at late follow-up. , 1995, Circulation.

[31]  W. Weaver,et al.  Relation between symptom duration before thrombolytic therapy and final myocardial infarct size. , 1996, Circulation.

[32]  P. Colonna,et al.  Analysis of microvascular integrity, contractile reserve, and myocardial viability after acute myocardial infarction by dobutamine echocardiography and myocardial contrast echocardiography. , 1996, The American journal of cardiology.

[33]  Harold L Skaggs,et al.  Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis , 1988 .